Purchase Order HT941023P2071
- Not listed
- The Defense Health Agency awarded a $200,000 firm fixed-price purchase order to RLS (USA) Inc. for radiopharmaceutical products, effective October 1, 2021, with completion targeted for September 30, 2023. This contract carries a Total Small Business set-aside designation and is performed in Tampa, Florida. RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, operates 31 radiopharmacy facilities across 18 states and specializes in supplying nuclear medicine...
- The Defense Health Agency awarded a $58,006.25 firm fixed-price purchase order to RLS (USA) Inc. for radiopharmaceuticals and related services to support the Department of Radiology Nuclear Medicine. The contract, awarded on October 1, 2025, with an ultimate completion date of September 30, 2026, represents a non-set-aside procurement for time-sensitive medical isotopes and diagnostic imaging agents required for nuclear medicine procedures at military treatment facilities. RLS (USA) Inc., a...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a $1.13 million firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 on December 1, 2023, with performance extending through November 30, 2026. The contract, which carries no set-aside designation, calls for the supply of radiopharmaceutical products to support nuclear medicine diagnostic and therapeutic imaging services. The...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a firm fixed-price purchase order valued at $882,014.09 by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 20 on March 1, 2020. The contract, which is set aside for 8(a) small businesses under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), calls for the supply of radiopharmaceuticals to support nuclear medicine diagnostic and therapeutic...
- RLS (USA) Inc., a radiopharmacy company headquartered in Lake Mary, Florida, was awarded a delivery order valued at $250,075.29 by the Department of Veterans Affairs' Northern California Health Care System (Veterans Integrated Service Network 21) for radiopharmaceuticals and radiopharmaceutical supplies. The contract, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, utilizes firm fixed-price pricing and is not designated as a set-aside contract. This delivery order...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 on January 1, 2026, for the supply of radiopharmaceuticals for nuclear medicine patients. The contract carries a firm fixed-price ceiling value of $493,958.37 with an ultimate completion date of December 31, 2026, and will be performed in Lake Mary, Florida. This delivery order is not designated as a set-aside contract and...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, received a $431,476 firm fixed-price delivery order from the Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) for cyclotron radiopharmaceuticals with a performance period from April 1, 2026 through March 31, 2027. This delivery order was awarded without a set-aside designation and represents a call against one of RLS (USA) Inc.'s existing Indefinite Delivery Vehicles with...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a firm fixed-price purchase order valued at $1,747,515.93 by the Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), on March 1, 2026, for the supply of radiopharmaceuticals and nuclear medicine products. This unrestricted acquisition, with no set-aside designation, will support diagnostic imaging procedures at the Clement J. Zablocki VA Medical Center in...
- The Department of Veterans Affairs, Veterans Integrated Service Network 20 (VISN 20), awarded a $315,075.54 firm fixed-price purchase order to RLS (USA) Inc. for radiopharmaceutical products on September 1, 2025, with completion targeted for December 31, 2025. The contract carries no set-aside designation and represents a direct procurement from the Lake Mary, Florida-based vendor, a foreign-owned radiopharmacy company specializing in nuclear medicine diagnostic and therapeutic imaging agents....
- This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The $833,285.36 firm fixed-price purchase order has a performance period ending on June 22, 2023. RLS (USA) Inc. is a small business that specializes in supplying critical molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear...
RLS (USA) Inc., a radiopharmacy company headquartered in Lake Mary, Florida, was awarded a $204,216.35 firm fixed-price purchase order by the Defense Health Agency on October 1, 2023, as a Total Small Business Set-Aside contract. The award supports radiopharmaceutical supply requirements for the Radiology Department at Naval Hospital Camp Pendleton in California. The contract calls for the delivery of 18 radiopharmaceutical products including diagnostic imaging agents such as gallium-67, fluorodeoxyglucose F-18, technetium-99m, and other specialized nuclear medicine compounds essential for diagnostic and therapeutic procedures. The performance period extends through September 30, 2026, structured as a one-year base period with two one-year option periods. RLS (USA) Inc. operates 31 radiopharmacy facilities across 18 states, positioning it as a critical supplier to federal healthcare agencies including the Department of Veterans Affairs and the Defense Health Agency. The company was selected based on technical capability, past performance, and price reasonableness. This purchase order complements RLS's broader portfolio of federal contracts with the Defense Health Agency and VA networks, including multiple indefinite delivery contracts and blanket purchase agreements valued at several million dollars, demonstrating the government's confidence in the company's capacity to reliably deliver time-sensitive radiopharmaceutical products to military treatment facilities and VA medical centers nationwide.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RADIOPHARMECUTICAL | HT941023Q2059 | Defense Health Agency | Award Notice 2/2 | 10/2/23, 4:08 PM | |
RADIOPHARMECUTICAL | HT941023Q2059 | Defense Health Agency | Solicitation 1/2 | 9/7/23, 6:44 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Funding Only Action | $100.0k | 1/7/26 | |
| P00005 | Exercise an Option | $0 | 8/7/25 | |
| P00004 | Funding Only Action | ($96k) | 6/3/25 | |
| P00003 | Funding Only Action | $100.0k | 11/8/24 | |
| P00002 | Exercise an Option | $0 | 8/22/24 |